China Cord Blood ROE 2010-2018 | CO

Current and historical return on equity (ROE) values for China Cord Blood (CO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. China Cord Blood ROE for the three months ending September 30, 2018 was 7.53%.
China Cord Blood ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.03B $0.48B 5.62%
2018-06-30 $0.03B $0.48B 5.92%
2018-03-31 $0.04B $0.50B 8.23%
2017-12-31 $0.04B $0.47B 8.65%
2017-09-30 $0.03B $0.45B 9.13%
2017-06-30 $0.02B $0.43B 7.89%
2017-03-31 $0.02B $0.27B 6.11%
2016-12-31 $0.01B $0.26B 4.98%
2016-09-30 $0.01B $0.26B 4.94%
2016-06-30 $0.01B $0.26B 5.37%
2016-03-31 $0.01B $0.27B 5.40%
2015-12-31 $0.01B $0.26B 6.74%
2015-09-30 $0.01B $0.25B 3.93%
2015-06-30 $0.01B $0.26B 4.82%
2015-03-31 $0.01B $0.00B 7.48%
2014-12-31 $0.01B $0.00B 7.29%
2014-09-30 $0.02B $0.24B 8.03%
2014-06-30 $0.02B $0.24B 8.16%
2014-03-31 $0.02B $0.23B 8.39%
2013-12-31 $0.02B $0.23B 8.24%
2013-09-30 $0.02B $0.23B 8.15%
2013-06-30 $0.02B $0.21B 8.53%
2013-03-31 $0.02B $0.20B 8.77%
2012-12-31 $0.02B $0.19B 9.86%
2012-09-30 $0.02B $0.19B 10.53%
2012-06-30 $0.02B $0.19B 10.75%
2012-03-31 $0.02B $0.20B 11.55%
2011-12-31 $0.02B $0.18B 11.46%
2011-09-30 $0.02B $0.18B 10.64%
2011-06-30 $0.02B $0.17B 10.79%
2011-03-31 $0.01B $0.17B 9.67%
2010-12-31 $0.01B $0.16B 6.77%
2010-09-30 $0.01B $0.13B 6.57%
2010-06-30 $0.01B $0.12B 7.10%
2010-03-31 $0.01B $0.12B 9.76%
2009-12-31 $0.01B $0.12B 17.31%
Sector Industry Market Cap Revenue
Medical Medical Services $0.714B $0.149B
Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $54.491B 11.26
ICON (ICLR) Ireland $7.026B 22.02
PRA Health Sciences (PRAH) United States $6.251B 25.52
Charles River Laboratories (CRL) United States $5.784B 20.28
Premier (PINC) United States $4.948B 16.79
INC Research Holdings (SYNH) United States $4.262B 17.20
HealthEquity (HQY) United States $3.720B 72.72
Teladoc (TDOC) United States $3.356B 0.00
NovoCure (NVCR) Jersey $3.225B 0.00
AMN Healthcare Services Inc (AMN) United States $2.584B 17.73
BioTelemetry (BEAT) United States $1.963B 34.67
Medpace Holdings (MEDP) United States $1.832B 22.67
IKang Healthcare (KANG) China $1.410B 70.00
Intrexon (XON) United States $1.073B 0.00
Healthways (TVTY) United States $1.057B 13.01
CareDx (CDNA) United States $0.948B 0.00
Natera (NTRA) United States $0.822B 0.00
Surgery Partners (SGRY) United States $0.568B 0.00
Apollo Medical Holdings (AMEH) United States $0.567B 0.00
Civitas Solutions (CIVI) United States $0.540B 9.84
Establishment Labs Holdings (ESTA) $0.467B 0.00
OncoCyte (OCX) United States $0.059B 0.00
Interpace Diagnostics (IDXG) United States $0.027B 0.00
OpGen (OPGN) United States $0.009B 0.00
Cancer Genetics (CGIX) United States $0.009B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00